Prognostic relevance of glycosylation-associated genes in breast cancer

Breast Cancer Research and Treatment

Volumn 145, Issue 2, 2014, Pages 295-305

  Milde Langosch, Karin ^a   Karn, Thomas ^b   Schmidt, Marcus ^c   Zu Eulenburg, Christine ^a   Oliveira Ferrer, Leticia ^a   Wirtz, Ralph M ^d   Schumacher, Udo ^a   Witzel, Isabell ^a   Schütze, Dina ^a   Müller, Volkmar ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d STRATIFYER Molecular Pathology GmbH   (Germany)

Author keywords

Breast cancer; Glycan genes; Glycosylation; Microarray analysis; Prognosis

Indexed keywords

GLYCOLIPID; GLYCOSAMINOGLYCAN; MESSENGER RNA; ALPHA LEVO FUCOSIDASE; BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE; DOLICHYL-PHOSPHATE BETA-D-MANNOSYLTRANSFERASE; ENZYME; FUCA1 PROTEIN, HUMAN; FUCOSYLTRANSFERASE; GALACTOSIDE 2-ALPHA-L-FUCOSYLTRANSFERASE; MANNOSIDASE; MANNOSYL-OLIGOSACCHARIDE 1,2-ALPHA-MANNOSIDASE; MANNOSYLTRANSFERASE; POLYPEPTIDE FUCOSYLTRANSFERASE; SIALYLTRANSFERASE; TUMOR MARKER;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PROGNOSIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; DISTANT METASTASIS; DPM1 GENE; FUCA1 GENE; FUCOSYLATION; FUT1 GENE; GCNT4 GENE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GLYCOSYLATION; GLYCOSYLATION ASSOCIATED GENE; HUMAN; MAJOR CLINICAL STUDY; MAN1A1 GENE; MOLECULAR PATHOLOGY; NUCLEOTIDE SEQUENCE; ONCOGENE; POFUT1 GENE; PREDICTIVE VALUE; PRIORITY JOURNAL; RPN1 GENE; SIGNAL TRANSDUCTION; ST3GAL6 GENE; TREND STUDY; UGCG GENE; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; LYMPH NODE; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

ALPHA-L-FUCOSIDASE; BREAST NEOPLASMS; COHORT STUDIES; ENZYMES; FEMALE; FUCOSYLTRANSFERASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; MANNOSIDASES; MANNOSYLTRANSFERASES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SIALYLTRANSFERASES; TUMOR MARKERS, BIOLOGICAL;

EID: 84901691729     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-2949-z     Document Type: Article

References (40)

1. Afratis N, Gialeli C, Nikitovic D, Tsegenidis T, Karousou E, Theocharis AD, Pavao MS, Tzanakakis GN, Karamanos NK (2012) Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J 279:1177-1197. doi: 10.1111/j.1742-4658.2012.08529.x
2. Arcaro KF, Wang J, Otis CN, Zuckerman BM (2004) Beta-galactosidase and alpha-mannosidase inhibit formation of multicellular nodules in breast cancer cell cultures. Anticancer Res 24:139-144 (Pubitemid 38279699)
3. Auvinen P, Tammi R, Parkkinen J, Tammi M, Agren U, Johansson R, Hirvikoski P, Eskelinen M, Kosma VM (2000) Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 156:529-536. doi: 10.1016/S0002-9440(10)64757-8 (Pubitemid 30643808)
4. Brockhausen I (2006) Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep 7:599-604 (Pubitemid 43827326)
5. Brockhausen I (1999) Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1473:67-95
6. Carvalho AS, Harduin-Lepers A, Magalhaes A, Machado E, Mendes N, Costa LT, Matthiesen R, Almeida R, Costa J, Reis CA (2010) Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells. Int J Biochem Cell Biol 42:80-89. doi: 10.1016/j.biocel.2009.09.010
7. Cazet A, Julien S, Bobowski M, Burchell J, Delannoy P (2010) Tumour-associated carbohydrate antigens in breast cancer. Breast Cancer Res BCR 12:204. doi: 10.1186/bcr2577
8. Contessa JN, Bhojani MS, Freeze HH, Ross BD, Rehemtulla A, Lawrence TS (2010) Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy. Clin Cancer Res 16:3205-3214. doi: 10.1158/1078-0432.CCR-09-3331
9. Cooney CA, Jousheghany F, Yao-Borengasser A, Phanavanh B, Gomes T, Kieber-Emmons AM, Siegel ER, Suva LJ, Ferrone S, Kieber-Emmons T, Monzavi-Karbassi B (2011) Chondroitin sulfates play a major role in breast cancer metastasis: A role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Res BCR 13:R58. doi: 10.1186/bcr2895
10. Gotte M, Yip GW (2006) Heparanase, hyaluronan, and CD44 in cancers: A breast carcinoma perspective. Cancer Res 66:10233-10237. doi: 10.1158/0008-5472.CAN-06-1464 (Pubitemid 44799736)
11. Goupille C, Marionneau S, Bureau V, Hallouin F, Meichenin M, Rocher J, Le Pendu J (2000) Alpha1,2fucosyltransferase increases resistance to apoptosis of rat colon carcinoma cells. Glycobiology 10:375-382 (Pubitemid 30184608)
12. Guo Q, Guo B, Wang Y, Wu J, Jiang W, Zhao S, Qiao S, Wu Y (2012) Functional analysis of alpha1,3/4-fucosyltransferase VI in human hepatocellular carcinoma cells. Biochem Biophys Res Commun 417:311-317. doi: 10.1016/j.bbrc.2011.11.106
13. Hatakeyama S, Kyan A, Yamamoto H, Okamoto A, Sugiyama N, Suzuki Y, Yoneyama T, Hashimoto Y, Koie T, Yamada S, Saito H, Arai Y, Fukuda M, Ohyama C (2010) Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor. Int J Cancer 127:1052-1059. doi: 10.1002/ijc.25117
14. Hu YY, Zheng MH, Zhang R, Liang YM, Han H (2012) Notch signaling pathway and cancer metastasis. Adv Exp Med Biol 727:186-198. doi: 10.1007/978-1-4614- 0899-4-14
15. Ihnen M, Muller V, Wirtz RM, Schroder C, Krenkel S, Witzel I, Lisboa BW, Janicke F, Milde-Langosch K (2008) Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer. Breast Cancer Res Treat 112(3):419-427
16. Julien S, Ivetic A, Grigoriadis A, QiZe D, Burford B, Sproviero D, Picco G, Gillett C, Papp SL, Schaffer L, Tutt A, Taylor-Papadimitriou J, Pinder SE, Burchell JM (2011) Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers. Cancer Res 71:7683-7693. doi: 10.1158/0008-5472.CAN-11-1139
17. Kanoh A, Ota M, Narimatsu H, Irimura T (2003) Expression levels of FUT6 gene transfected into human colon carcinoma cells switch two sialyl-Lewis X-related carbohydrate antigens with distinct properties in cell adhesion. Biochem Biophys Res Commun 303:896-901 (Pubitemid 36384939)
18. Karn T, Metzler D, Ruckhaberle E, Hanker L, Gatje R, Solbach C, Ahr A, Schmidt M, Holtrich U, Kaufmann M, Rody A (2010) Data-driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer. Breast Cancer Res Treat 120:567-579. doi: 10.1007/s10549-009-0416-z
19. Kikuchi J, Ozaki H, Nonomura C, Shinohara H, Iguchi S, Nojiri H, Hamada H, Kiuchi A, Nakamura M (2005) Transfection of antisense core 2 beta1,6-N-acetylglucosaminyltransferase-1 cDNA suppresses selectin ligand expression and tissue infiltration of B-cell precursor leukemia cells. Leukemia 19:1934-1940. doi: 10.1038/sj.leu.2403951 (Pubitemid 41554002)
20. Lau KS, Dennis JW (2008) N-Glycans in cancer progression. Glycobiology 18:750-760. doi: 10.1093/glycob/cwn071
21. Listinsky JJ, Siegal GP, Listinsky CM (2011) The emerging importance of alpha-l-fucose in human breast cancer: A review. Am J Transl Res 3:292-322
22. Martinez P, Vergoten G, Colomb F, Bobowski M, Steenackers A, Carpentier M, Allain F, Delannoy P, Julien S (2013) Over-sulfated glycosaminoglycans are alternative selectin ligands: insights into molecular interactions and possible role in breast cancer metastasis. Clin Exp Metastasis. doi: 10.1007/s10585-013- 9592-7
23. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2006) REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 100:229-235 (Pubitemid 44631925)
24. Milde-Langosch K, Karn T, Muller V, Witzel I, Rody A, Schmidt M, Wirtz RM (2013) Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer. Breast Cancer Res Treat 137:57-67. doi: 10.1007/s10549-012-2296-x
25. Miles FL, Pruitt FL, van Golen KL, Cooper CR (2008) Stepping out of the flow: capillary extravasation in cancer metastasis. Clin Exp Metastasis 25:305-324 (Pubitemid 351748980)
26. Moremen KW, Tiemeyer M, Nairn AV (2012) Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol 13:448-462. doi: 10.1038/nrm3383
27. Nairn AV, Aoki K, dela Rosa M, Porterfield M, Lim JM, Kulik M, Pierce JM, Wells L, Dalton S, Tiemeyer M, Moremen KW (2012) Regulation of glycan structures in murine embryonic stem cells: combined transcript profiling of glycan-related genes and glycan structural analysis. J Biol Chem 287:37835-37856. doi: 10.1074/jbc.M112.405233
28. Perez-Garay M, Arteta B, Llop E, Cobler L, Pages L, Ortiz R, Ferri MJ, de Bolos C, Figueras J, de Llorens R, Vidal-Vanaclocha F, Peracaula R (2013) Alpha2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues. Int J Biochem Cell Biol 45:1748-1757. doi: 10.1016/j.biocel.2013.05.015
29. Potapenko IO, Haakensen VD, Luders T, Helland A, Bukholm I, Sorlie T, Kristensen VN, Lingjaerde OC, Borresen-Dale AL (2010) Glycan gene expression signatures distinguish normal and malignant breast tissue; possible role in diagnosis and progression. EJC Suppl 8:102
30. Renkonen J, Rabina J, Mattila P, Grenman R, Renkonen R (2001) Core 2 beta1,6-N-acetylglucosaminyltransferases and alpha1,3-fucosyltransferases regulate the synthesis of O-glycans on selectin ligands on oral cavity carcinoma cells. APMIS Acta Pathol Microbiol Immunol Scand 109:500-506 (Pubitemid 32844257)
31. Roberts JD, Klein JL, Palmantier R, Dhume ST, George MD, Olden K (1998) The role of protein glycosylation inhibitors in the prevention of metastasis and therapy of cancer. Cancer Detect Prev 22:455-462 (Pubitemid 28395563)
32. Schmidt M, Bohm D, von Torne C, Steiner E, Puhl A, Pilch H, Lehr HA, Hengstler JG, Kolbl H, Gehrmann M (2008) The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res 68:5405-5413
33. Shirure VS, Henson KA, Schnaar RL, Nimrichter L, Burdick MM (2011) Gangliosides expressed on breast cancer cells are E-selectin ligands. Biochem Biophys Res Commun 406:423-429. doi: 10.1016/j.bbrc.2011.02.061
34. Stern R (2005) Hyaluronan metabolism: A major paradox in cancer biology. Pathol Biol 53:372-382. doi: 10.1016/j.patbio.2004.12.021 (Pubitemid 41112071)
35. Suzuki Y, Sutoh M, Hatakeyama S, Mori K, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Habuchi T, Arai Y, Fukuda M, Ohyama C, Tsuboi S (2012) MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis. Int J Oncol 40:1831-1838. doi: 10.3892/ijo.2012.1411
36. Taylor-Papadimitriou J, Epenetos AA (1994) Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy. Trends Biotechnol 12:227-233. doi: 10.1016/0167-7799(94)90121-X (Pubitemid 24190550)
37. Udabage L, Brownlee GR, Waltham M, Blick T, Walker EC, Heldin P, Nilsson SK, Thompson EW, Brown TJ (2005) Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer. Cancer Res 65:6139-6150. doi: 10.1158/0008-5472.CAN-04-1622 (Pubitemid 40994399)
38. Varki A, Lowe JB (2009) Biological roles of glycans. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME (eds) Essentials of glycobiology. Cold Spring Harbor, New York
39. Yuan K, Kucik D, Singh RK, Listinsky CM, Listinsky JJ, Siegal GP (2008) Alterations in human breast cancer adhesion-motility in response to changes in cell surface glycoproteins displaying alpha-l-fucose moieties. Int J Oncol 32:797-807 (Pubitemid 351780590)
40. Yuan K, Listinsky CM, Singh RK, Listinsky JJ, Siegal GP (2008) Cell surface associated alpha-l-fucose moieties modulate human breast cancer neoplastic progression. Pathol Oncol Res POR 14:145-156. doi: 10.1007/s12253-008-9036-x